+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Veloxis Pharmaceuticals A/S - logo

Veloxis Pharmaceuticals is a commercial-stage specialty pharmaceutical company that operates in Europe and the United States. Veloxis’ products include tacrolimus extended-release tablets called Envarsus XR and MeltDose, which is designed to enhance the absorption and bioavailability of select orally administered drugs. The company was formerly known as LifeCycle Pharma A/S and changed its name to Veloxis Pharmaceuticals A/S in July 2011. Veloxis is based in Copenhagen, Denmark.

From
From
From
From
Liver Transplant Rejection - Pipeline Review, H2 2020 - Product Thumbnail Image

Liver Transplant Rejection - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 73 pages
From
Kidney Transplant Rejection - Pipeline Review, H2 2020 - Product Thumbnail Image

Kidney Transplant Rejection - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 191 pages
From
From
Global Immunosuppressant Drugs Market 2019-2028 - Product Thumbnail Image

Global Immunosuppressant Drugs Market 2019-2028

  • Report
  • July 2020
  • 178 pages
From
From
Europe Immunosuppressant Drugs Market 2019-2028 - Product Thumbnail Image

Europe Immunosuppressant Drugs Market 2019-2028

  • Report
  • July 2020
  • 121 pages
From
From
From
From
From
From
Envarsus XR 2019 U.S. Promotional Audit Report - Product Thumbnail Image

Envarsus XR 2019 U.S. Promotional Audit Report

  • Report
  • July 2020
  • 24 pages
From
Loading Indicator
adroll